Mining adverse events in large frequency tables with ontology, with an application to the vaccine adverse event reporting system
dc.contributor.author | Zhao, Bangyao | |
dc.contributor.author | Zhao, Lili | |
dc.date.accessioned | 2023-05-01T19:11:34Z | |
dc.date.available | 2024-06-01 15:11:32 | en |
dc.date.available | 2023-05-01T19:11:34Z | |
dc.date.issued | 2023-05-10 | |
dc.identifier.citation | Zhao, Bangyao; Zhao, Lili (2023). "Mining adverse events in large frequency tables with ontology, with an application to the vaccine adverse event reporting system." Statistics in Medicine 42(10): 1512-1524. | |
dc.identifier.issn | 0277-6715 | |
dc.identifier.issn | 1097-0258 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/176293 | |
dc.publisher | John Wiley & Sons, Inc. | |
dc.subject.other | adverse event ontology | |
dc.subject.other | zero-inflated negative binomial distribution | |
dc.subject.other | VAERS | |
dc.subject.other | vaccine adverse event | |
dc.subject.other | empirical Bayes | |
dc.title | Mining adverse events in large frequency tables with ontology, with an application to the vaccine adverse event reporting system | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Public Health | |
dc.subject.hlbsecondlevel | Medicine (General) | |
dc.subject.hlbsecondlevel | Statistics and Numeric Data | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.subject.hlbtoplevel | Science | |
dc.subject.hlbtoplevel | Social Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/176293/1/sim9684_am.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/176293/2/sim9684.pdf | |
dc.identifier.doi | 10.1002/sim.9684 | |
dc.identifier.source | Statistics in Medicine | |
dc.identifier.citedreference | Khuri AI. Applications of Dirac’s delta function in statistics. Int J Math Edu Sci Technol. 2004; 35 ( 2 ): 185 - 195. doi: 10.1080/00207390310001638313 | |
dc.identifier.citedreference | Mozzicato P. MedDRA: an overview of the medical dictionary for regulatory activities. Pharm Med. 2009; 23: 65 - 75. | |
dc.identifier.citedreference | Li R, Stewart B, Weintraub E, McNeil MM. Continuous sequential boundaries for vaccine safety surveillance. Stat Med. 2014; 33: 3387 - 3397. | |
dc.identifier.citedreference | Kulldorff M, Dashevsky I, Avery TR, et al. Drug safety data mining with a tree-based scan statistic. Pharmacoepidemiol Drug Saf. 2013; 22: 517 - 523. | |
dc.identifier.citedreference | Huang J, Cai Y, Du J, et al. Monitoring vaccine safety by studying temporal variation of adverse events using vaccine adverse event reporting system. Anna Appl Stat. 2021; 15 ( 1 ): 252 - 269. doi: 10.1214/20-AOAS1393 | |
dc.identifier.citedreference | Cai Y, Du J, Huang J, et al. A signal detection method for temporal variation of adverse effect with vaccine adverse event reporting system data. BMC Med Inform Decis Mak. 2017; 17 ( 2 ): 93 - 100. | |
dc.identifier.citedreference | Zeileis A, Kleiber C, Jackman S. Regression models for count data in R. J Stat Software. 2008; 27 ( 8 ): 1 - 25. doi: 10.18637/jss.v027.i08 | |
dc.identifier.citedreference | Li S, Zhao L. Vaccine adverse event enrichment tests. Stat Med. 2021; 40 ( 19 ): 4269 - 4278. | |
dc.identifier.citedreference | Woo EJ, Mba-Jonas A, Dimova RB, Alimchandani M, Zinderman CE, Nair N. Association of Receipt of the Ad26. COV2. S COVID-19 vaccine with presumptive Guillain-Barré syndrome, February-July 2021. Jama. 2021; 326 ( 16 ): 1606 - 1613. | |
dc.identifier.citedreference | Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021. Jama. 2021; 325 ( 11 ): 1101 - 1102. | |
dc.identifier.citedreference | Lambkin-Williams R, Gelder C, Broughton R, et al. An intranasal proteosome-adjuvanted trivalent influenza vaccine is safe, immunogenic and efficacious in the human viral influenza challenge model. Serum IgG and mucosal IgA are important correlates of protection against illness associated with infection. PLoS one. 2016; 11: e0163089. | |
dc.identifier.citedreference | Haber P, Moro PL, Cano M, Lewis P, Stewart B, Shimabukuro T. Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine adverse event reporting system(VAERS), July 2013–June 2014. Vaccine. 2015; 33: 1987 - 1992. | |
dc.identifier.citedreference | Baxtera R, Eatona A, Hansena J, Aukesa L, Caspardb H, Ambroseba CS. Safety of quadrivalent live attenuated influenza vaccinein subjects aged 2–49 years. Vaccine. 2017; 35: 1254 - 1258. | |
dc.identifier.citedreference | Zhao L, Lee S, Li R, Ong E, He Y, Freed G. Improvement in the analysis of vaccine adverse event reporting system database. Stat Biopharm Res. 2020; 12: 1 - 14. doi: 10.1080/19466315.2020.1764862 | |
dc.identifier.citedreference | Ding Y, Markatou M, Ball R. An evaluation of statistical approaches to postmarketing surveillance. Stat Med. 2020; 39 ( 7 ): 845 - 874. doi: 10.1002/sim.8447 | |
dc.identifier.citedreference | Huang L, Zalkikar J, Tiwari RC. A likelihood ratio test based method for signal detection with application to FDA’s drug safety data. J Am Stat Assoc. 2011; 106 ( 496 ): 1230 - 1241. doi: 10.1198/jasa.2011.ap10243 | |
dc.identifier.citedreference | Thissen D, Steinberg L, Kuang D. Quick and easy implementation of the Benjamini-Hochberg procedure for controlling the false positive rate in multiple comparisons. J Edu Behavior Stat. 2002; 27 ( 1 ): 77 - 83. | |
dc.identifier.citedreference | Varricchio F, Iskander J, DeStefano F, et al. Understanding vaccine safety information from the vaccine adverse event reporting system. Pediatr Infect Dis J. 2004; 23: 287 - 294. | |
dc.identifier.citedreference | Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Safety monitoring in the vaccine adverse event reporting system (VAERS). Vaccine. 2015; 33 ( 36 ): 4398 - 4405. | |
dc.identifier.citedreference | DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat. 1999; 53 ( 3 ): 177 - 190. | |
dc.identifier.citedreference | DuMouchel W, Pregibon D. Empirical Bayes screening for multi-item associations. In Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. San Francisco, CA; 2001: 67 - 76. | |
dc.identifier.citedreference | Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001; 10: 483 - 486. | |
dc.identifier.citedreference | Puijenbroek vEP, Bate A, Leufkens HG, Lindquist M, RO R, Egberts AC. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002; 11: 3 - 10. | |
dc.identifier.citedreference | Bate A, Lindquist M, Edwards IR, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998; 54: 315 - 321. | |
dc.identifier.citedreference | Lansner ROA, Bate A, IRE ML, et al. Bayesian neural networks with confidence estimations applied to data mining. Comput Stat Data Anal. 2000; 34: 473 - 493. | |
dc.identifier.citedreference | Nóren GN, Bate A, Orre R, Edwards IR. Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events. BCPNN. 2006; 25: 3740 - 3757. | |
dc.identifier.citedreference | Szarfman A, Machado SG, O’Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA’s spontaneous reports database. PLoS ONE. 2002; 25: 381 - 392. | |
dc.identifier.citedreference | Kulldorff M, Davis RL, Kolczak M, Lewis E, Lieu T, Platt R. A maximized sequential probability ratio test for drug and vaccine safety surveillance. Sequential Anal. 2011; 30: 58 - 78. | |
dc.identifier.citedreference | Davis RL, Kolczak M, Lewis E, et al. Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology. 2005; 16: 336 - 341. | |
dc.identifier.citedreference | Li L, Kulldorff M. A conditional maximized sequential probability ratio test for pharmacovigilance. Stat Med. 2009; 29: 284 - 295. | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.